Your search for "disease" return 42 results.
Vector vaccines symposium - 23th September 2010 >
CEVA will hold its first vector vaccines symposium in San Diego, USA from october 6-8th2010. Together with presenting its advanced technology, the forum will encourage the sharing of worldwide experie...
Contributions >
An astounding 75% of emerging human diseases are of animal origin. Ceva is making a huge contribution in the global fight against brucellosis, avian flu, and other zoonoses such as Q-fever, trypanosom...
Vaccination equipment >
With the evolution of the technologies used in poultry production, more and more producers are capable of realizing the benefits of concentrating their vaccination activities in hatcheries. Vaccinat...
Poultry >
Poultry vaccine technology is one of our company’s core specialties.
Vaccine >
Combining the long tradition of vaccine development of Ceva Phylaxia in Hungary and the cutting edge technology of Biomune in USA the company is committed to develop innovative vaccines that can meet...
Parasiticides >
Ceva develops ruminants parasiticides products to control external parasites & internal as well
Other parasiticides >
Ceva develops ruminants parasiticides products to control external parasites & internal as well
Blood parasiticides >
For over 20 years Ceva Santé Animale has led the way in developing a more innovative range of products perfectly adapted to the control of African animal diseases. VERIBEN ® Trypanocide leader f...
Our operations >
Ceva is fully operational in the Ruminant and Poultry markets. We have an adapted range for inter-tropical diseases, we have dedicated Research and Development, Production and Distribution operation.....
Foreword of operational Manager >
Proud of our commitment on the African continent for over 25 years, a sincere and reliable relation allows us to invest and to accompany Africa in its fight against specific diseases. The continuou...